Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Mercurity Fintech | MFH | 15. jan 2025 | 6.83 | +21.96 |
Mercury General | MCY | 15. jan 2025 | 52.90 | +8.07 |
Mercury Systems | MRCY | 15. jan 2025 | 43.28 | +0.63 |
Mereo BioPharma ADR | MREO | 15. jan 2025 | 3.03 | -0.98 |
Meridian | MRBK | 15. jan 2025 | 15.02 | +4.38 |
MeridianLink | MLNK | 15. jan 2025 | 19.38 | +2.27 |
Merit Medical Systems | MMSI | 15. jan 2025 | 101.53 | +1.64 |
Meritage Homes | MTH | 15. jan 2025 | 80.58 | +2.62 |
Merrill Lynch & Co. | IPB | 15. jan 2025 | 25.43 | -0.27 |
Mersana Therapeutics | MRSN | 15. jan 2025 | 0.64 | +1.03 |
Merus N.V | MRUS | 15. jan 2025 | 39.34 | +0.86 |
Mesa Air Group | MESA | 15. jan 2025 | 1.31 | -2.24 |
Mesa Laboratories | MLAB | 15. jan 2025 | 135.08 | +3.08 |
Mesa Royalty Trust | MTR | 15. jan 2025 | 6.50 | +0.48 |
Mesabi Royalty Trust | MSB | 15. jan 2025 | 27.00 | +0.97 |
Mesoblast ADR | MESO | 15. jan 2025 | 17.10 | +0.71 |
Meta Platforms A | META | 15. jan 2025 | 617.12 | +3.85 |
Metagenomi | MGX | 15. jan 2025 | 2.80 | +1.45 |
Metal Sky Star Acquisition | MSSA | 15. jan 2025 | 11.80 | +1.46 |
Metalla Royalty & Streaming | MTA | 15. jan 2025 | 2.72 | +2.26 |
Metallus | MTUS | 15. jan 2025 | 14.99 | +4.31 |
MetaVia | MTVA | 15. jan 2025 | 1.96 | 0.00 |
Methalpa Technology Holding | MATH | 15. jan 2025 | 1.56 | +2.96 |
Methanex | MEOH | 15. jan 2025 | 50.19 | +1.46 |
Methode Electronics | MEI | 15. jan 2025 | 12.18 | +3.84 |
MetLife | MET | 15. jan 2025 | 84.93 | +1.31 |
Metlife Pref A | MET-A | 15. jan 2025 | 25.11 | +0.44 |
Metlife Pref E | MET-E | 15. jan 2025 | 23.67 | +2.78 |
Metlife Pref F | MET-F | 15. jan 2025 | 20.49 | +2.09 |
MetroCity Bankshares | MCBS | 15. jan 2025 | 31.98 | +2.37 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.